While the company is well-recognized domestically, Korea’s biotech industry as a whole has historically faced challenges in gaining global recognition. Despite producing groundbreaking science, Korean ...

A new study found that patients with type 2 diabetes treated with GLP-1 receptor agonists and sodium-glucose cotransporter-2 ...

How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

How is artificial intelligence shaking up the pharma marketing space? Ted Sweetser: The first top level one that everyone is ...

Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, discusses getting JUV-161 into Phase I trials this year.